Stock IdeasStrong Buy Stocks
Strong Buy Stocks from Top Wall Street Analysts
Latest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen

Analyst / FirmCompanyPriceRatingPrice TargetUpside/DownsideDate
Kristen Kluska
Cantor Fitzgerald
Top 3%
98
Lexeo Therapeutics IncLXEO
$3.23Strong Buy$37.00+1,045.51%
a day ago
Analyst Ranking
Top 3%
#135 out of 5561 analysts
Average Return
+23.56%
Win Rate
41%107 out of 264
Risk vs Reward
Poor
Good

Analyst Color

Cantor Fitzgerald's Kristen Kluska raised their price target on Lexeo Therapeutics (NASDAQ: LXEO) by 60.9% from $23 to $37 on 2026/11/16. The analyst maintained their Strong Buy rating on the stock.

Raising their price target on Lexeo Therapeutics, Kluska referenced Phase 1/2 interim data for LX2020 for PKP2 arrthymogenic cardiomyopathy, headlining that the data evidence a meaningful improvement from 2026/01, with broad effects observed throughout, including non-sustained ventricular tachycardia.

The analyst said they now have a much higher conviction in the program.

Philippe Houchois
Jefferies
Top 19%
82
Tesla IncTSLA
$800.00Strong Buy$850.00+6.25%
2 days ago

Upgrade to Premium to View More

Strong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts

Already have access to Premium? Sign In
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.